Cited by 402Pituitary Gland Disorders and TreatmentsAdrenal and Paraganglionic TumorsAdrenal Hormones and Disorders

The European Registry on Cushing’s syndrome: 2-year experience. Baseline demographic and clinical characteristics

Valassi, Elena, Santos, Alicia, Yaneva, Maria, Tóth, Miklós, Strasburger, Christian J, Chanson, Philippe, Wass, John A H, Chabre, Olivier +10 more·2011·European Journal of Endocrinology

Abstract

Objective: The European Registry on Cushing's syndrome (ERCUSYN) is designed to collect prospective and follow-up data at EU level on Cushing's syndrome (CS). Design and methods: Baseline data on 481 CS patients (390 females, 91 males; mean age (± s.d. ): 44±14 years) collected from 36 centres in 23 countries, including new patients from 2008 and retrospective cases since 2000. Patients were divided into four major aetiologic groups: pituitary-dependent CS (PIT-CS) (66%), adrenal-dependent CS (ADR-CS) (27%), CS from an ectopic source (ECT-CS) (5%) and CS from other aetiologies (2%). Results: Proportion of men in the ECT-CS group was higher than in the other groups ( P <0.05). The ADR-CS group was older than the PIT-CS ( P <0.05). Prevalence of hirsutism (92%) and diabetes (74%) in ECT-CS was higher than in the other groups ( P <0.05 and P <0.01 respectively). PIT-CS had more skin alterations, menstrual irregularities and hirsutism than ADR-CS ( P <0.01). Reduced libido was more prevalent in men than women ( P <0.01). Prevalence of spine osteoporosis was higher in men than women ( P <0.05), and males had more vertebral and rib fractures than females (52 vs 18% for vertebrae; P <0.001 and 34 vs 23% for ribs; P <0.05). ECT-CS consulted a diabetologist more frequently than ADR-CS ( P <0.05), while a gynaecologist was consulted more often by women with PIT-CS or ADR-CS than with ECT-CS ( P <0.05). Overall, weight gain was more common in women than men ( P <0.01). CushingQoL and EuroQoL visual analogue scale scores did not differ between the groups. Conclusions: The ERCUSYN project demonstrates a heterogeneous clinical presentation of CS at a European level, depending on gender and aetiology.

Integrity signals

Registry

Crossref · 10.1530/eje-11-0272

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Among patients with endogenous Cushing syndrome, 20% to 45% have diabetes and 10% to 30% have defective glucose tolerance, so overall prevalence of glucose metabolism impairment can approach 70%.

    “From % to % of patients with endogenous CS have DM, and % to % have defective glucose tolerance, so the overall prevalence of glucose metabolism impairments can come close to %, as shown in Table  (, , -).”

Cites

Flagged first, then by citations

1 of the 36 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Valassi, E., Santos, A., Yaneva, M., Tóth, M., Strasburger, C. J., Chanson, P., Wass, J. A. H., Chabre, O., Pfeifer, M., Feelders, R. A., Tsagarakis, S., Trainer, P. J., Franz, H., Zopf, K., Zacharieva, S., Lamberts, S. W. J., Tabarin, A., & Webb, S. M.
Affiliations
  • Universitat Autònoma de Barcelona (ES)
  • Medical University of Sofia (BG)
  • Semmelweis University (HU)
  • Charité – Universitätsmedizin Berlin (DE)
  • Université Paris-Sud (FR)
  • Churchill Hospital (GB)
  • Ljubljana University Medical Centre (SI)
  • Erasmus MC (NL)
  • Polyclinic General Hospital (GR)
  • The Christie Hospital (GB)
  • Centre Hospitalier Universitaire de Bordeaux (FR)
Corresponding author
Valassi, Elena
Venue
European Journal of Endocrinology
Published
2011-09
Volume
165
Issue
3
Pages
383-392
ISSN
  • 0804-4643 (ISSN-L)
  • 1479-683X
OpenAlex
W2171877884
Cited by
402
References
36
Citations by year
2026: 28 · 2025: 25 · 2024: 27 · 2023: 29 · 2022: 44 · 2021: 31 · 2020: 27 · 2019: 24 · 2018: 35 · 2017: 20 · 2016: 23 · 2015: 38 · 2014: 19 · 2013: 15 · 2012: 15
FWCI
12.86
Type
journal article
Language
en
Open access
closed
Locations
  • European Journal of Endocrinology (publishedVersion)
  • PubMed (publishedVersion)
  • Research Explorer (The University of Manchester) (publishedVersion)
  • EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
  • Digital Access to Libraries (Université catholique de Louvain (UCL), l'Université de Namur (UNamur) and the Université Saint-Louis (USL-B)) (submittedVersion)
Funders
European Commission
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
  • Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
Keywords
Cushing's syndrome, pituitary-dependent Cushing's disease, ectopic ACTH syndrome, clinical features, sex differences, hirsutism, diabetes mellitus, osteoporosis, quality of life, EuroQol, patient registry
MeSH terms
Adolescent, Adrenal Gland Neoplasms, Adult, Aged, Aged, 80 and over, Bone Diseases, Metabolic, Cushing Syndrome, Europe, Female, Humans, Male, Middle Aged, Pituitary Neoplasms, Prospective Studies, Quality of Life, Registries, Retrospective Studies, Cohort Studies, Prevalence, Fractures, Bone

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review